Tento web používá soubory cookie ke zlepšení Vašeho zážitku. Budeme předpokládat, že s tím souhlasíte, ale můžete se odhlásit, pokud si přejete. Více informací
Year: 2021
Study on the treatment of people with 5q-SMA with nusinersen in adulthood
Treatment with the drug nusinersen is available for people with 5q-associated spinal muscular atrophy (5q-SMA). In our application study with people with 5q-SMA who received nusinersen therapy in adulthood, the treatment goals, symptom progression and treatment satisfaction with the drug were systematically investigated. In the period from July 2019 to September 2020, Ambulanzpartner conducted an…